Proto Script Pharmaceutical Corp.
PSCR · OTC
12/31/2016 | 12/31/2015 | 5/31/2014 | 5/31/2013 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $4 | $9 | $0 | $35 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $140 | $174 | $0 | $1 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $1 | $0 | $0 | $0 |
| Total Curr. Assets | $145 | $184 | $0 | $36 |
| Property Plant & Equip (Net) | $26 | $15 | $0 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $26 | $15 | $0 | $0 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $170 | $199 | $0 | $36 |
| Liabilities | – | – | – | – |
| Payables | $157 | $24 | $18 | $4 |
| Short-Term Debt | $51 | $36 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $281 | $77 | $10 | $4 |
| Total Curr. Liab. | $490 | $137 | $28 | $8 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $0 | $0 | $0 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $490 | $137 | $28 | $8 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $344 | $300 | $3 | $3 |
| Retained Earnings | -$7,617 | -$238 | -$137 | -$81 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $6,953 | $0 | $106 | $106 |
| Total Equity | -$320 | $62 | -$28 | $28 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $170 | $199 | $0 | $36 |
| Net Debt | $48 | $27 | -$0 | -$35 |